Literature DB >> 11704373

Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes.

M Ai1, A Tanaka, K Ogita, M Sekinc, F Numano, F Numano, G M Reaven.   

Abstract

OBJECTIVES: The goal of this study was to evaluate the relative effects of hyperglycemia and hyperinsulinemia on postprandial remnant lipoprotein (RLP) concentrations in newly diagnosed type 2 diabetics.
BACKGROUND: Increases in fasting RLP concentration have been described in type 2 diabetics, as well as in insulin-resistant nondiabetics. Given the atherogenicity of RLPs, we have extended these observations by assessing postprandial RLP concentrations and observing that hyperglycemia was necessary for the increase in RLP concentrations.
METHODS: Patients with type 2 diabetes were subdivided on the basis of their plasma insulin response to oral glucose into hyperinsulinemic (H-DM) and normoinsulinemic (N-DM) groups of 15 patients each. Plasma triglyceride (TG), RLP-TG and RLP cholesterol (RLP-C) concentrations were determined before and 2 and 4 h after an oral fat load in these patients and 10 control (CTL) subjects.
RESULTS: Plasma TG, RLP-TG and RLP-C concentrations peaked 2 h after the fat load in the CTL group, returning to baseline within 4 h. In contrast, concentrations of these variables increased throughout the 4-h study in both groups of patients with type 2 diabetes. Total integrated plasma RLP-TG and RLP-C responses above baseline after the oral fat load were significantly higher in the H-DM group compared with the CTL (p = 0.019 and 0.009, respectively) or N-DM (p = 0.026 and 0.029, respectively) groups. Post-heparin lipoprotein lipase activities and apo E phenotypes were similar in the H-DM and N-DM groups.
CONCLUSIONS: Remnant lipoprotein response to an oral fat load is significantly increased in hyperinsulinemic patients with type 2 diabetes. These changes may increase the risk of coronary heart disease in these individuals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704373     DOI: 10.1016/s0735-1097(01)01611-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  20 in total

Review 1.  Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Yoshiharu Tokita; Takeaki Nagamine; Akihiro Inazu; Junji Kobayashi; Hiroshi Mabuchi; Kimber L Stanhope; Peter J Havel; Mitsuyo Okazaki; Masumi Ai; Akira Tanaka
Journal:  Clin Chim Acta       Date:  2011-04-19       Impact factor: 3.786

Review 2.  Remnant lipoproteins and atherosclerosis.

Authors:  ThB Twickler; G M Dallinga-Thie; M J Chapman; J S Cohn
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

3.  Pitavastatin prevents postprandial endothelial dysfunction via reduction of the serum triglyceride level in obese male subjects.

Authors:  Hirotaka Nagashima; Masahiro Endo
Journal:  Heart Vessels       Date:  2010-12-04       Impact factor: 2.037

4.  Association between postprandial remnant-like particle triglyceride (RLP-TG) levels and carotid intima-media thickness (IMT) in Japanese patients with type 2 diabetes: assessment by meal tolerance tests (MTT).

Authors:  Yutaka Mori; Yohta Itoh; Hideaki Komiya; Naoko Tajima
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

5.  Effects of nateglinide on the elevation of postprandial remnant-like particle triglyceride levels in Japanese patients with type 2 diabetes assessment by meal tolerance test.

Authors:  Yutaka Mori; Genshin Kuriyama; Naoko Tajima
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

6.  APOB-516 T allele homozygous subjects are unresponsive to dietary changes in a three-month primary intervention study targeted to reduce fat intake.

Authors:  Ahd Hammoud; Marguerite Gastaldi; Matthieu Maillot; Charles S Mercier; Catherine Defoort; Denis Lairon; Richard Planells
Journal:  Genes Nutr       Date:  2009-10-20       Impact factor: 5.523

7.  Postprandial lipemia is modified by the presence of the APOB-516C/T polymorphism in a healthy Caucasian population.

Authors:  Pablo Pérez-Martínez; Francisco Pérez-Jiménez; José María Ordovás; Juan Antonio Moreno; Carmen Marín; Rafael Moreno; Yolanda Jiménez-Gómez; Juan Antonio Paniagua; José López-Miranda
Journal:  Lipids       Date:  2007-02-10       Impact factor: 1.880

8.  Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.

Authors:  Zareen M Farukhi; Olga V Demler; Michael P Caulfield; Krishnaji Kulkarni; Jay Wohlgemuth; Michael Cobble; Heike Luttmann-Gibson; Chunying Li; John R Nelson; Nancy R Cook; Julie E Buring; Ronald M Krauss; JoAnn E Manson; Samia Mora
Journal:  J Clin Lipidol       Date:  2020-02-21       Impact factor: 4.766

9.  Reduced first-phase insulin secretion increases postprandial lipidemia in subjects with impaired glucose tolerance.

Authors:  Miguel Ángel Gómez-Sámano; Daniel Cuevas-Ramos; Mariana Grajales-Gómez; Marco Escamilla-Márquez; Angelina López-Estrada; Luz Elizabeth Guillén-Pineda; Guadalupe López-Carrasco; Francisco J Gómez-Pérez
Journal:  BMJ Open Diabetes Res Care       Date:  2017-05-08

10.  Fasting remnant lipoproteins can predict postprandial hyperlipidemia.

Authors:  Tomoki Nagata; Daisuke Sugiyama; Takako Kise; Satomi Tsuji; Hideo Ohira; Itsuko Sato; Mari Yamamoto; Hitomi Kohsaka; Seiji Kawano; Shizuya Yamashita; Yuichi Ishikawa; Yoshio Fujioka
Journal:  Lipids Health Dis       Date:  2012-10-31       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.